Literature DB >> 26029651

Atypical developmental venous anomaly associated with contrast enhancement and hyperperfusion in the surrounding basal ganglia.

Neslin Sahin1, Aynur Solak1, Berhan Genc1, Nalan Bilgic1.   

Abstract

Developmental venous anomalies (DVAs) are the most common type of cerebral vascular malformations. They are generally accepted as variants of venous development and frequently identified incidentally, particularly on contrast-enhanced MR imaging. Most of the DVAs do not affect the integrity of the surrounding parenchyma. This article discusses an atypical DVA which is associated with contrast enhancement and increased perfusion within the drainage territory of the DVA, probably due to anomalous venous drainage. These unusual perfusion patterns of the DVAs should be differentiated from other entities such as hypervascular brain tumors or ischemia with hemodynamical changes which have different clinical management.

Entities:  

Keywords:  Developmental venous anomaly (DVA); perfusion MR imaging; susceptibility-weighted imaging

Year:  2015        PMID: 26029651      PMCID: PMC4426117          DOI: 10.3978/j.issn.2223-4292.2014.09.02

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  11 in total

1.  High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique.

Authors:  J R Reichenbach; L Jonetz-Mentzel; C Fitzek; E M Haacke; D K Kido; B C Lee; W A Kaiser
Journal:  Neuroradiology       Date:  2001-05       Impact factor: 2.804

2.  Brain parenchymal signal abnormalities associated with developmental venous anomalies: detailed MR imaging assessment.

Authors:  G M Santucci; J L Leach; J Ying; S D Leach; T A Tomsick
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-16       Impact factor: 3.825

3.  Association of developmental venous anomalies with perfusion abnormalities on arterial spin labeling and bolus perfusion-weighted imaging.

Authors:  Michael Iv; Nancy J Fischbein; Greg Zaharchuk
Journal:  J Neuroimaging       Date:  2014-04-09       Impact factor: 2.486

4.  Atypical MR imaging perfusion in developmental venous anomalies.

Authors:  Daniel L A Camacho; J Keith Smith; John D Grimme; Harold F Keyserling; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions.

Authors:  B C Lee; K D Vo; D K Kido; P Mukherjee; J Reichenbach; W Lin; M S Yoon; M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  1999-08       Impact factor: 3.825

6.  Perfusion-CT of developmental venous anomalies: typical and atypical hemodynamic patterns.

Authors:  H Kroll; B P Soares; D Saloner; W P Dillon; M Wintermark
Journal:  J Neuroradiol       Date:  2009-12-02       Impact factor: 3.447

7.  Diffusion and perfusion MRI findings of the signal-intensity abnormalities of brain associated with developmental venous anomaly.

Authors:  H N Jung; S T Kim; J Cha; H J Kim; H S Byun; P Jeon; K H Kim; B-J Kim; H-J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

8.  Hemodynamic effects of developmental venous anomalies with and without cavernous malformations.

Authors:  A Sharma; G J Zipfel; C Hildebolt; C P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-18       Impact factor: 3.825

Review 9.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.

Authors:  S Mittal; Z Wu; J Neelavalli; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

10.  Venous congestion associated with developmental venous anomaly: findings on susceptibility weighted imaging.

Authors:  Shiori Amemiya; Shigeki Aoki; Hidemasa Takao
Journal:  J Magn Reson Imaging       Date:  2008-12       Impact factor: 4.813

View more
  1 in total

Review 1.  An Overview of Venous Abnormalities Related to the Development of Lesions in Multiple Sclerosis.

Authors:  E Mark Haacke; Yulin Ge; Sean K Sethi; Sagar Buch; Paolo Zamboni
Journal:  Front Neurol       Date:  2021-04-26       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.